Mesenchymal Stromal Cell Therapy in Lung Transplantation

Lung transplantation is often the only viable treatment option for a patient with end-stage lung disease. Lung transplant results have improved substantially over time, but ischemia-reperfusion injury, primary graft dysfunction, acute rejection, and chronic lung allograft dysfunction (CLAD) continue...

Descripción completa

Detalles Bibliográficos
Autores principales: Nykänen, Antti I., Liu, Mingyao, Keshavjee, Shaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295637/
https://www.ncbi.nlm.nih.gov/pubmed/37370659
http://dx.doi.org/10.3390/bioengineering10060728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295637/
https://www.ncbi.nlm.nih.gov/pubmed/37370659
http://dx.doi.org/10.3390/bioengineering10060728

Ejemplares similares